The new Oasmia board, led by Jörgen Olsson who was elected as the Chairman, independent Board member and former CEO of Hoist Finance, will review the business and proceedings of Oasmia in several aspects.
The company gave a list in the press release, as it says “to make it very clear”. The goal of the revision is to create the best value for the company and all shareholders going forward. Those are:
- A review of product and distribution strategy to ensure that Oasmia will succeed as planned. To increase possibilities to transform Company from a developing into a commercially successful life science company.
- To review the value of the Company, including the value of the Company including the assets and liabilities. To ensure the correctness in and off the Balance sheet.
- To review also the related transactions between different interested parties, such as closely related parties to ensure that the Company’s rights has correctly been taken into account in the accounting and can do so going forward.
- To review the transactions that have been made of issues of shares, options and convertibles. That these transactions have been made diligently so that all shareholders rights have been taken into account. To see that policies will be adopted for these rights to be taken into account in the future.
- To make sure that there are resources and measures to strengthen the communication to be transparent and correct going forward.
Olsson said that the board will strive to accomplish a more intense dialogue with the stock market and the company’s stakeholders, at the same time as it will see it as its duty, to make sure that all shareholders will take part of the same information at the same time.
“A more comprehensive report of our view of the situation will be reported upon our first Board Meeting due to April 2nd, and thereafter in the quarterly report due to June 5th,” says Olsson.